Virtual screening and molecular dynamics study of approved drugs as inhibitors of spike protein S1 domain and ACE2 interaction in SARS-CoV-2

BACKGROUND: The receptor binding domain (RBD) of spike protein S1 domain SARS-CoV-2 plays a key role in the interaction with ACE2, which leads to subsequent S2 domain mediated membrane fusion and incorporation of viral RNA into host cells. In this study we tend to repurpose already approved drugs as...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Mol Graph Model
Asıl Yazarlar: Prajapat, Manisha, Shekhar, Nishant, Sarma, Phulen, Avti, Pramod, Singh, Sanjay, Kaur, Hardeep, Bhattacharyya, Anusuya, Kumar, Subodh, Sharma, Saurabh, Prakash, Ajay, Medhi, Bikash
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Elsevier Inc. 2020
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7442136/
https://ncbi.nlm.nih.gov/pubmed/32866780
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jmgm.2020.107716
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller